CIRM welcomes Dr. Vito Imbasciani as new chair

Dr. Vito Imbasciani was sworn in as the new Chair of the CIRM Board at its March meeting. He was elected to a six‑year term at the January meeting and succeeds Jonathan Thomas, who has served since 2011. “My experience has positioned me to champion CIRM’s aims, advocate for it, and represent it responsibly to … Continue reading CIRM welcomes Dr. Vito Imbasciani as new chair

Meshing a passion for medicine with stem cell research

Kevin Brown is an adventurer at heart. As a pre‑med student, he found a way to combine his passion for neuroscience with his drive to explore through scientific research. A 2022 graduate of CIRM’s Bridges to Stem Cell Research and Therapy Program, Kevin says the experience let him merge his interest in medicine with his … Continue reading Meshing a passion for medicine with stem cell research

Why diversity in clinical trials is essential

The California Institute for Regenerative Medicine (CIRM) joins fellow advocates of clinical trial diversity in applauding a new law that will allow the U.S. Food & Drug Administration (FDA) to require diverse representation in clinical trials.  A clinical trial, as defined by the FDA, tests potential treatments in human volunteers to see whether they should … Continue reading Why diversity in clinical trials is essential